Livforsakringsbolaget Skandia’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-43,823
| Closed | -$1.09M | – | 488 |
|
|
2025
Q4 | $1.09M | Hold |
43,823
| – | – | 0.04% | 167 |
|
|
2025
Q3 | $1.12M | Sell |
43,823
-1,400
| -3% | -$34.6K | 0.04% | 181 |
|
|
2025
Q2 | $1.1M | Hold |
45,223
| – | – | 0.05% | 182 |
|
|
2025
Q1 | $1.15M | Hold |
45,223
| – | – | 0.06% | 182 |
|
|
2024
Q4 | $1.2M | Sell |
45,223
-265,550
| -85% | -$7.2M | 0.06% | 178 |
|
|
2024
Q3 | $8.99M | Buy |
310,773
+89,522
| +40% | +$2.61M | 0.48% | 52 |
|
|
2024
Q2 | $6.19M | Sell |
221,251
-3,400
| -2% | -$93.6K | 0.51% | 53 |
|
|
2024
Q1 | $6.23M | Hold |
224,651
| – | – | 0.53% | 48 |
|
|
2023
Q4 | $6.47M | Buy |
224,651
+5,924
| +3% | +$179K | 0.62% | 45 |
|
|
2023
Q3 | $7.26M | Sell |
218,727
-10,000
| -4% | -$354K | 0.8% | 29 |
|
|
2023
Q2 | $8.39M | Sell |
228,727
-22,700
| -9% | -$884K | 0.87% | 21 |
|
|
2023
Q1 | $10.3M | Sell |
251,427
-42,000
| -14% | -$1.81M | 1.07% | 15 |
|
|
2022
Q4 | $15M | Hold |
293,427
| – | – | 1.73% | 8 |
|
|
2022
Q3 | $12.8M | Sell |
293,427
-77,400
| -21% | -$3.76M | 1.59% | 8 |
|
|
2022
Q2 | $19.4M | Sell |
370,827
-19,700
| -5% | -$1M | 1.69% | 7 |
|
|
2022
Q1 | $20.2M | Buy |
390,527
+3,600
| +0.9% | +$187K | 1.35% | 11 |
|
|
2021
Q4 | $22.8M | Sell |
386,927
-25,700
| -6% | -$1.27M | 1.45% | 12 |
|
|
2021
Q3 | $17.7M | Sell |
412,627
-12,800
| -3% | -$567K | 1.11% | 12 |
|
|
2021
Q2 | $16.7M | Buy |
425,427
+28,500
| +7% | +$1.11M | 0.99% | 15 |
|
|
2021
Q1 | $14.4M | Buy |
396,927
+49,100
| +14% | +$1.74M | 1% | 14 |
|
|
2020
Q4 | $12.8M | Buy |
347,827
+4,932
| +1% | +$181K | 1.09% | 14 |
|
|
2020
Q3 | $11.9M | Sell |
342,895
-6,113
| -2% | -$214K | 1.28% | 11 |
|
|
2020
Q2 | $10.8M | Buy |
349,008
+3,478
| +1% | +$118K | 1.24% | 13 |
|
|
2020
Q1 | $10.7M | Buy |
345,530
+15,283
| +5% | +$521K | 1.51% | 10 |
|
|
2019
Q4 | $12.3M | Sell |
330,247
-21,185
| -6% | -$755K | 1.46% | 11 |
|
|
2019
Q3 | $12M | Hold |
351,432
| – | – | 1.42% | 11 |
|
|
2019
Q2 | $14.4M | Buy |
351,432
+8,854
| +3% | +$352K | 1.77% | 8 |
|
|
2019
Q1 | $13.8M | Buy |
342,578
+2,635
| +0.8% | +$106K | 1.82% | 7 |
|
|
2018
Q4 | $14.1M | Buy |
339,943
+2,108
| +0.6% | +$87.5K | 2.1% | 6 |
|
|
2018
Q3 | $14.1M | Sell |
337,835
-111,514
| -25% | -$4.29M | 1.68% | 6 |
|
|
2018
Q2 | $15.5M | Buy |
449,349
+15,178
| +3% | +$519K | 1.4% | 9 |
|
|
2018
Q1 | $14.6M | Buy |
434,171
+15,283
| +4% | +$525K | 1.41% | 7 |
|
|
2017
Q4 | $14.4M | Sell |
418,888
-23,188
| -5% | -$791K | 1.38% | 7 |
|
|
2017
Q3 | $15M | Hold |
442,076
| – | – | 1.34% | 8 |
|
|
2017
Q2 | $14.1M | Hold |
442,076
| – | – | 1.29% | 7 |
|
|
2017
Q1 | $14.3M | Sell |
442,076
-243,790
| -36% | -$7.69M | 1.34% | 6 |
|
|
2016
Q4 | $21.1K | Buy |
685,866
+575,367
| +521% | +$17.6M | 1.08% | 12 |
|
|
2016
Q3 | $5.17M | Sell |
110,499
-771,042
| -87% | -$25.8M | 0.25% | 90 |
|
|
2016
Q2 | $29.4M | Buy |
881,541
+69,985
| +9% | +$2.23M | 1.3% | 10 |
|
|
2016
Q1 | $22.8M | Hold |
811,556
| – | – | 1.07% | 15 |
|
|
2015
Q4 | $24.9M | Buy |
811,556
+44,374
| +6% | +$1.4M | 1.17% | 9 |
|
|
2015
Q3 | $22.9M | Hold |
767,182
| – | – | 1.2% | 9 |
|
|
2015
Q2 | $24.4M | Buy |
767,182
+23,082
| +3% | +$752K | 1.19% | 9 |
|
|
2015
Q1 | $24.6M | Sell |
744,100
-44,057
| -6% | -$1.4M | 1.21% | 9 |
|
|
2014
Q4 | $23.3M | Sell |
788,157
-222,499
| -22% | -$6.38M | 1.09% | 10 |
|
|
2014
Q3 | $28.4M | Sell |
1,010,656
-90,012
| -8% | -$2.53M | 1.07% | 13 |
|
|
2014
Q2 | $31M | Sell |
1,100,668
-65,488
| -6% | -$1.87M | 1.11% | 13 |
|
|
2014
Q1 | $35.5M | Buy |
1,166,156
+993,054
| +574% | +$29.6M | 1.33% | 10 |
|
|
2013
Q4 | $5.03M | Sell |
173,102
-37,944
| -18% | -$1.1M | 3.25% | 1 |
|
|
2013
Q3 | $5.75M | Sell |
211,046
-42,018
| -17% | -$1.14M | 3.98% | 1 |
|
|
2013
Q2 | $6.72M | Buy |
+253,064
| New | +$6.99M | 4.85% | 1 |
|
Other funds holding PFE
VCM
VPM
Livforsakringsbolaget Skandia's PFE Position: Q1 2026 in Review
Livforsakringsbolaget Skandia sold out of Pfizer (PFE) in Q1 2026, closing a stake of 43,823 shares — an estimated $1.09M sold.
Livforsakringsbolaget Skandia first reported a position in PFE in Q2 2013 and held it in 51 quarters. The position peaked at $35.5M in Q1 2014. 2,947 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Livforsakringsbolaget Skandia reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Livforsakringsbolaget Skandia sold 43,823 Pfizer shares in Q1 2026, an estimated $1.09M.
- Livforsakringsbolaget Skandia first reported a position in Pfizer in Q2 2013 and held it in 51 quarters.
- Livforsakringsbolaget Skandia's Pfizer position peaked at $35.5M in Q1 2014.
- 2,947 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.